These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 9195133)

  • 1. A metalloproteinase inhibitor blocks the shedding of soluble cytokine receptors and processing of transmembrane cytokine precursors in human monocytic cells.
    Gallea-Robache S; Morand V; Millet S; Bruneau JM; Bhatnagar N; Chouaib S; Roman-Roman S
    Cytokine; 1997 May; 9(5):340-6. PubMed ID: 9195133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor.
    Müllberg J; Durie FH; Otten-Evans C; Alderson MR; Rose-John S; Cosman D; Black RA; Mohler KM
    J Immunol; 1995 Dec; 155(11):5198-205. PubMed ID: 7594530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor.
    Alsalameh S; Mattka B; Al-Ward R; Lorenz HM; Manger B; Pfizenmaier K; Grell M; Kalden JR
    J Rheumatol; 1999 Mar; 26(3):645-53. PubMed ID: 10090177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF alpha processing in RA synovial membrane cell cultures.
    Williams LM; Gibbons DL; Gearing A; Maini RN; Feldmann M; Brennan FM
    J Clin Invest; 1996 Jun; 97(12):2833-41. PubMed ID: 8675695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma.
    Galve-de Rochemonteix B; Nicod LP; Dayer JM
    Am J Respir Cell Mol Biol; 1996 Mar; 14(3):279-87. PubMed ID: 8845179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of expression of transmembrane and soluble 75 kDa tumor necrosis factor receptors by interferon-gamma and granulocyte-macrophage colony-stimulating factor involves transcriptional activation.
    Mylius-Spencker H; Winzen R; Resch K; Holtmann H
    Eur Cytokine Netw; 1997 Dec; 8(4):351-8. PubMed ID: 9459614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-alpha, the great imitator: role of p55 and p75 TNF receptors in hematopoiesis.
    Jacobsen SE; Jacobsen FW; Fahlman C; Rusten LS
    Stem Cells; 1994; 12 Suppl 1():111-26; discussion 126-8. PubMed ID: 7535144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential responses of fibroblasts from wild-type and TNF-R55-deficient mice to mouse and human TNF-alpha activation.
    Mackay F; Rothe J; Bluethmann H; Loetscher H; Lesslauer W
    J Immunol; 1994 Dec; 153(11):5274-84. PubMed ID: 7525730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes.
    Joyce DA; Gibbons DP; Green P; Steer JH; Feldmann M; Brennan FM
    Eur J Immunol; 1994 Nov; 24(11):2699-705. PubMed ID: 7957562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimerization of chimeric erythropoietin/75 kDa tumour necrosis factor (TNF) receptors transduces TNF signals: necessity for the 75 kDa-TNF receptor transmembrane domain.
    Declercq W; Vandenabeele P; Fiers W
    Cytokine; 1995 Oct; 7(7):701-9. PubMed ID: 8580379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of repeated administration of granulocyte colony-stimulating factor (G-CSF) on neutrophil counts, plasma cytokine, and cytokine receptor levels.
    Pollmächer T; Korth C; Schreiber W; Hermann D; Mullington J
    Cytokine; 1996 Oct; 8(10):799-803. PubMed ID: 8980882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells.
    Panja A; Goldberg S; Eckmann L; Krishen P; Mayer L
    J Immunol; 1998 Oct; 161(7):3675-84. PubMed ID: 9759892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of methotrexate on differentiation of monocytes and production of cytokine inhibitors by monocytes.
    Seitz M; Zwicker M; Loetscher P
    Arthritis Rheum; 1998 Nov; 41(11):2032-8. PubMed ID: 9811059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms.
    Zhang Y; McCluskey K; Fujii K; Wahl LM
    J Immunol; 1998 Sep; 161(6):3071-6. PubMed ID: 9743373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Processing of tumour necrosis factor-alpha precursor by metalloproteinases.
    Gearing AJ; Beckett P; Christodoulou M; Churchill M; Clements J; Davidson AH; Drummond AH; Galloway WA; Gilbert R; Gordon JL
    Nature; 1994 Aug; 370(6490):555-7. PubMed ID: 8052310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor.
    McGeehan GM; Becherer JD; Bast RC; Boyer CM; Champion B; Connolly KM; Conway JG; Furdon P; Karp S; Kidao S
    Nature; 1994 Aug; 370(6490):558-61. PubMed ID: 8052311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HepG2 human hepatoma cells express multiple cytokine genes.
    Stonāns I; Stonāne E; Russwurm S; Deigner HP; Böhm KJ; Wiederhold M; Jäger L; Reinhart K
    Cytokine; 1999 Feb; 11(2):151-6. PubMed ID: 10089137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ONO-4007, an antitumor lipid A analog, induces tumor necrosis factor-alpha production by human monocytes only under primed state: different effects of ONO-4007 and lipopolysaccharide on cytokine production.
    Matsumoto N; Aze Y; Akimoto A; Fujita T
    J Pharmacol Exp Ther; 1998 Jan; 284(1):189-95. PubMed ID: 9435177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and cleavage of tumor necrosis factor-alpha and tumor necrosis factor receptors by human monocytic cell lines upon direct contact with stimulated T cells.
    Vey E; Burger D; Dayer JM
    Eur J Immunol; 1996 Oct; 26(10):2404-9. PubMed ID: 8898953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fc alpha receptors mediate release of tumour necrosis factor-alpha and interleukin-6 by human monocytes following receptor aggregation.
    Patry C; Herbelin A; Lehuen A; Bach JF; Monteiro RC
    Immunology; 1995 Sep; 86(1):1-5. PubMed ID: 7590867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.